BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17336840)

  • 1. Immunohistochemical evidence of nerve growth factor in Dupuytren's diseased palmar fascia.
    Lubahn JD; Pollard M; Cooney T
    J Hand Surg Am; 2007 Mar; 32(3):337-42. PubMed ID: 17336840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
    Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
    J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptors in Dupuytren's contracture.
    Pagnotta A; Specchia N; Greco F
    J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords.
    Dave SA; Banducci DR; Graham WP; Allison GM; Ehrlich HP
    Exp Mol Pathol; 2001 Oct; 71(2):147-55. PubMed ID: 11599921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
    Tomasek J; Rayan GM
    J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a novel gene, MafB, in Dupuytren's disease.
    Lee LC; Zhang AY; Chong AK; Pham H; Longaker MT; Chang J
    J Hand Surg Am; 2006 Feb; 31(2):211-8. PubMed ID: 16473681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feedback inhibition of high TGF-beta1 concentrations on myofibroblast induction and contraction by Dupuytren's fibroblasts.
    Wong M; Mudera V
    J Hand Surg Br; 2006 Oct; 31(5):473-83. PubMed ID: 16875762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myofibroblasts of palmar fibromatosis co-express transforming growth factor-alpha and epidermal growth factor receptor.
    Magro G; Lanteri E; Micali G; Paravizzini G; Travali S; Lanzafame S
    J Pathol; 1997 Feb; 181(2):213-7. PubMed ID: 9120728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of ED-A and ED-B containing fibronectin isoforms in Dupuytren's disease.
    Halliday NL; Rayan GM; Zardi L; Tomasek JJ
    J Hand Surg Am; 1994 May; 19(3):428-34. PubMed ID: 8056970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular structure and biology of Dupuytren's disease.
    Tomasek JJ; Vaughan MB; Haaksma CJ
    Hand Clin; 1999 Feb; 15(1):21-34. PubMed ID: 10050239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibronectin filaments and actin microfilaments are organized into a fibronexus in Dupuytren's diseased tissue.
    Tomasek JJ; Haaksma CJ
    Anat Rec; 1991 Jun; 230(2):175-82. PubMed ID: 1867394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine manipulation of explanted Dupuytren's affected human palmar fascia.
    Kuhn MA; Payne WG; Kierney PC; Pu LL; Smith PD; Siegler K; Ko F; Wang X; Robson MC
    Int J Surg Investig; 2001; 2(6):443-56. PubMed ID: 12678125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-catenin overexpression in Dupuytren's disease is unrelated to disease recurrence.
    Degreef I; De Smet L; Sciot R; Cassiman JJ; Tejpar S
    Clin Orthop Relat Res; 2009 Mar; 467(3):838-45. PubMed ID: 18958538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Dupuytren's disease caused by an imbalance between proliferation and cell death?
    Jemec B; Grobbelaar AO; Wilson GD; Smith PJ; Sanders R; McGrouther DA
    J Hand Surg Br; 1999 Oct; 24(5):511-4. PubMed ID: 10597921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
    J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve growth factor (NGF) and NGF-receptor expression in diseased human kidneys.
    Bonofiglio R; Antonucci MT; Papalia T; Romeo F; Capocasale G; Caroleo MC; Di Fausto V; Aloe L
    J Nephrol; 2007; 20(2):186-95. PubMed ID: 17514623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular actin as a marker for myofibroblasts in vitro.
    Foo IT; Naylor IL; Timmons MJ; Trejdosiewicz LK
    Lab Invest; 1992 Dec; 67(6):727-33. PubMed ID: 1460863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy?
    Bianchi E; Taurone S; Bardella L; Signore A; Pompili E; Sessa V; Chiappetta C; Fumagalli L; Di Gioia C; Pastore FS; Scarpa S; Artico M
    Clin Sci (Lond); 2015 Oct; 129(8):711-20. PubMed ID: 26201022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF beta and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin.
    Berndt A; Kosmehl H; Mandel U; Gabler U; Luo X; Celeda D; Zardi L; Katenkamp D
    Histochem J; 1995 Dec; 27(12):1014-20. PubMed ID: 8789403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression analysis of Dupuytren's disease: the role of TGF-beta2.
    Zhang AY; Fong KD; Pham H; Nacamuli RP; Longaker MT; Chang J
    J Hand Surg Eur Vol; 2008 Dec; 33(6):783-90. PubMed ID: 18694919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.